Emma

Emma Health is a private digital health company focused on microbiome-based chronic condition management. The company provides a Microbiome Intelligence Care Platform that combines microbiome testing, AI-driven insights, clinical decision support, and personalized care pathways for patients and providers. Its current disease focus areas highlighted publicly include irritable bowel syndrome, Alzheimer's disease or cognitive decline, obesity, and autoimmune disease. Rather than developing traditional drug therapeutics, Emma Health appears to commercialize a care platform and evidence-informed intervention programs built around microbiome modulation, natural supplements, and lifestyle guidance. The company also partners with provider organizations to integrate microbiome-informed care into clinical practice.